Showing results (341-350 of 390) with videos related to

Sort By:
Pageof 39
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 9, 2022
The relationship between processing speed and verbal and non-verbal new learning and memory in progressive multiple sclerosisNancy D Chiaravalloti, John DeLuca, Amber Salter, et al.
Advances in Therapy|May 5, 2019
Multiple Sclerosis Performance Test: Technical Development and UsabilityJane K Rhodes, David Schindler, Stephen M Rao, et al.
European Journal of Neurology|November 9, 2021
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trialsMatteo Garibaldi, Tommaso Nicoletti, Elisabetta Bucci, et al.
JAMA Neurology|July 30, 2019
Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients With Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) StudyAmrou Sarraj, Ameer E Hassan, Sean Savitz, et al.
Multiple Sclerosis and Related Disorders|March 12, 2017
Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypothesesGavin Giovannoni, Gary Cutter, Maria Pia Sormani, et al.
Neurorehabilitation and Neural Repair|April 25, 2026
Looking Beyond Dose: Identifying Responders and Non-Responders to RehaCom Computerized Cognitive Rehabilitation in Progressive MS-The CogEx StudyCecilia Meza, Roberto S Hernandez, Silvana L Costa, et al.
Multiple Sclerosis and Related Disorders|November 20, 2025
Adherence and compliance with exercise training in progressive multiple sclerosis: Rates and correlates from the CogEx trialRobert W Motl, Andrew Argie, Roberto S Hernandez, et al.
Frontiers in Neurology|July 17, 2026
Rituximab in Myasthenia Gravis: a real-world study using inverse probability of treatment weightingYong Lin Wang, Chao Zhu, Mahima Kapoor, et al.
Journal of Neurology|September 23, 2025
Effects of cognitive rehabilitation and exercise on brain structure in progressive multiple sclerosis: results from the CogEx trialFrancesco Romanò, Maria A Rocca, Elisabetta Pagani, et al.
The New England Journal of Medicine|August 24, 2022
Ublituximab versus Teriflunomide in Relapsing Multiple SclerosisLawrence Steinman, Edward Fox, Hans-Peter Hartung, et al.
Pageof 39